| Product Code: ETC13364457 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Pediatric Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Pediatric Vaccine Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Pediatric Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Pediatric Vaccine Market - Industry Life Cycle |
3.4 Africa Pediatric Vaccine Market - Porter's Five Forces |
3.5 Africa Pediatric Vaccine Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Pediatric Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Africa Pediatric Vaccine Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 Africa Pediatric Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Africa Pediatric Vaccine Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Africa Pediatric Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
4 Africa Pediatric Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Pediatric Vaccine Market Trends |
6 Africa Pediatric Vaccine Market, 2021 - 2031 |
6.1 Africa Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Pediatric Vaccine Market, Revenues & Volume, By Live Attenuated, 2021 - 2031 |
6.1.3 Africa Pediatric Vaccine Market, Revenues & Volume, By Inactivated, 2021 - 2031 |
6.1.4 Africa Pediatric Vaccine Market, Revenues & Volume, By Subunit, 2021 - 2031 |
6.1.5 Africa Pediatric Vaccine Market, Revenues & Volume, By Toxoid, 2020 - 2028 |
6.1.6 Africa Pediatric Vaccine Market, Revenues & Volume, By Conjugate, 2020 - 2028 |
6.2 Africa Pediatric Vaccine Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Pediatric Vaccine Market, Revenues & Volume, By Respiratory Infections, 2021 - 2031 |
6.2.3 Africa Pediatric Vaccine Market, Revenues & Volume, By Gastrointestinal Diseases, 2021 - 2031 |
6.2.4 Africa Pediatric Vaccine Market, Revenues & Volume, By Neurological Diseases, 2021 - 2031 |
6.2.5 Africa Pediatric Vaccine Market, Revenues & Volume, By Bloodborne Diseases, 2021 - 2031 |
6.2.6 Africa Pediatric Vaccine Market, Revenues & Volume, By Bacterial Infections, 2020 - 2028 |
6.3 Africa Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Pediatric Vaccine Market, Revenues & Volume, By mRNA, 2021 - 2031 |
6.3.3 Africa Pediatric Vaccine Market, Revenues & Volume, By Recombinant, 2021 - 2031 |
6.3.4 Africa Pediatric Vaccine Market, Revenues & Volume, By DNA-Based, 2021 - 2031 |
6.3.5 Africa Pediatric Vaccine Market, Revenues & Volume, By Viral Vector, 2021 - 2031 |
6.3.6 Africa Pediatric Vaccine Market, Revenues & Volume, By Protein Subunit, 2021 - 2031 |
6.4 Africa Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Pediatric Vaccine Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Africa Pediatric Vaccine Market, Revenues & Volume, By Pediatric Clinics, 2021 - 2031 |
6.4.4 Africa Pediatric Vaccine Market, Revenues & Volume, By Research Institutes, 2020 - 2028 |
6.4.5 Africa Pediatric Vaccine Market, Revenues & Volume, By Government Programs, 2020 - 2028 |
6.4.6 Africa Pediatric Vaccine Market, Revenues & Volume, By Pharmacies, 2020 - 2028 |
6.5 Africa Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Africa Pediatric Vaccine Market, Revenues & Volume, By Infants, 2020 - 2028 |
6.5.3 Africa Pediatric Vaccine Market, Revenues & Volume, By Children, 2020 - 2028 |
6.5.4 Africa Pediatric Vaccine Market, Revenues & Volume, By Adolescents, 2020 - 2028 |
6.5.5 Africa Pediatric Vaccine Market, Revenues & Volume, By Neonates, 2020 - 2028 |
6.5.6 Africa Pediatric Vaccine Market, Revenues & Volume, By Pre-Teens, 2020 - 2028 |
7 Africa Pediatric Vaccine Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.1 South Africa Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.2 Egypt Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.3 Nigeria Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.4 Rest of Africa Pediatric Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3 Africa Pediatric Vaccine Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
7.3.1 South Africa Pediatric Vaccine Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.2 Egypt Pediatric Vaccine Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.3 Nigeria Pediatric Vaccine Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.4 Rest of Africa Pediatric Vaccine Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4 Africa Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.1 South Africa Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.2 Egypt Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.3 Nigeria Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.4 Rest of Africa Pediatric Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5 Africa Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 South Africa Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Egypt Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Nigeria Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.4 Rest of Africa Pediatric Vaccine Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 Africa Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.6.1 South Africa Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.6.2 Egypt Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.6.3 Nigeria Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.6.4 Rest of Africa Pediatric Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
8 Africa Pediatric Vaccine Market Key Performance Indicators |
9 Africa Pediatric Vaccine Market - Export/Import By Countries Assessment |
10 Africa Pediatric Vaccine Market - Opportunity Assessment |
10.1 Africa Pediatric Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Pediatric Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10.3 Africa Pediatric Vaccine Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
10.4 Africa Pediatric Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.5 Africa Pediatric Vaccine Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 Africa Pediatric Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
11 Africa Pediatric Vaccine Market - Competitive Landscape |
11.1 Africa Pediatric Vaccine Market Revenue Share, By Companies, 2022 |
11.2 Africa Pediatric Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here